Search
01/08/2023
Novel pharmacological approaches in abdominal aortic aneurysm
Puertas-Umbert, L, Almendra-Pegueros, R, Jimenez-Altayo, F, Sirvent, M, Galan, M, Martinez-Gonzalez, J, Rodriguez, C. Novel pharmacological approaches in abdominal aortic aneurysm. CLINICAL SCIENCE. 2023; 137(15)DOI:10.1042/CS20220795. PMID:37559446. IF:6.700(Q1/2D).
01/08/2023
Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism
Lee-Rueckert, M, Canyelles, M, Tondo, M, Rotllan, N, Kovanen, PT, Llorente-Cortes, V, Escola-Gil, JC. Obesity-induced changes in cancer cells and their microenvironment: Mechanisms and therapeutic perspectives to manage dysregulated lipid metabolism. SEMINARS IN CANCER BIOLOGY. 2023; 93DOI:10.1016/j.semcancer.2023.05.002. PMID:37156344. IF:12.100(Q1/1D).
01/08/2023
Quality of life in pituitary diseases.
Webb SM, Valassi E. Quality of life in pituitary diseases.. Endocrinologia Diabetes y Nutricion. 2023; 70(7)DOI:10.1016/j.endien.2023.03.021. PMID:37516611. IF:(Q/D).
01/08/2023
Patient journey of individuals tested for HCV in Spain: LiverTAI, a retrospective analysis of EHRs through natural language processing
Calleja Panero J.L., de la Poza G., Hidalgo L., Aguilera Sancho-Tello M.V., Torras X., Santos de Lamadrid R., Maté C., Sánchez Antolín G.. Patient journey of individuals tested for HCV in Spain: LiverTAI, a retrospective analysis of EHRs through natural language processing. Gastroenterologia y Hepatologia. 2023; 46(7)DOI:10.1016/j.gastrohep.2022.10.012. PMID:36273653. IF:2.200(Q3/6D).